Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
White Fund SA is a Belgian venture capital fund established in October 2019, with a financial capacity of €38 million. The fund focuses on supporting early-stage projects in the medtech sector, aiming to enhance the Belgian medtech ecosystem and improve patient care. Founded by investment professionals Joanna Tyrekidis and Benoit Fellin, White Fund seeks to make a significant impact in the life sciences and investment sectors.
As of now, White Fund manages a portfolio of 11 companies and initiates 2 to 3 investments annually. The firm is headquartered in Liège, Belgium, and primarily invests in Belgium and neighboring countries. The fund's commitment to early-stage commercialization is reflected in its investment strategy, which targets projects with a solid proof of concept or initial turnover.
White Fund SA invests in a variety of medical technologies, including prevention, diagnostics, monitoring, and treatment solutions. The fund primarily targets early-stage projects that are entering commercialization, requiring a sound proof of concept or initial turnover. Investment tickets typically range from €2 million to €5 million per project, with potential for larger investments through co-investment strategies.
The firm emphasizes its dedication to enhancing patient care through innovative medical technologies. White Fund's investment strategy is designed to support projects that not only demonstrate technological viability but also have the potential for significant market impact. The fund's geographic focus is primarily on Belgium, but it remains open to opportunities in neighboring European countries.
White Fund SA has a diverse portfolio of 11 companies, reflecting its commitment to the medtech sector. Notable portfolio companies include:
White Fund initiates 2 to 3 investments per year, demonstrating its active engagement in the medtech space.
Joanna Tyrekidis - Co-founder and investment professional with extensive experience in venture capital and the life sciences sector.
Benoit Fellin - Co-founder and investment professional, specializing in early-stage investments in healthcare.
Michel Baijot - Chairman of the board, brings a wealth of experience in investment management.
Pierre Mercenier - Director at OGEO Fund, with a background in venture capital.
Francois Fontaine - Director at SFPI-FPIM, experienced in public investment strategies.
Gaetan Servais - Director at Noshaq, with expertise in supporting startups.
Filip Goossens - Senior Investment Manager at PMV, focusing on early-stage investments.
Laurence Carabin - Observer from CHU Liège, contributing insights from the healthcare sector.
Mathilde Levy - Observer from Finance & Invest. Brussels, with a focus on investment strategies.
Marc Nolet - Observer with experience in venture capital.
Claude Melen - Observer from Solidaris, providing healthcare sector insights.
To pitch White Fund, startups should send their proposals via email to info@whitefund.be. The pitch deck should include a clear overview of the business model, market analysis, and details about the technology. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
As of March 2023, White Fund has continued to actively invest in the medtech space, initiating 2 to 3 investments annually. The firm has made notable investments in companies such as EarlyTracks, EndoTools, and MoveUp, reinforcing its commitment to enhancing the Belgian medtech ecosystem.
In 2022, White Fund announced its focus on supporting early-stage projects that aim to improve patient care through innovative medical technologies. The fund's strategy includes targeting projects with a solid proof of concept and initial turnover, aligning with its mission to impact the life sciences sector positively.
What are White Fund's investment criteria?
White Fund primarily invests in early-stage medtech projects that are entering commercialization. The fund looks for companies with a solid proof of concept or initial turnover, focusing on medical technologies that enhance patient care.
How can startups apply or pitch to White Fund?
Startups can pitch to White Fund by sending an email to info@whitefund.be. It is advisable to include a detailed business plan and information about the technology and market potential in the pitch deck.
What makes White Fund different from other venture capital firms?
White Fund differentiates itself through its exclusive focus on the medtech sector and its commitment to enhancing the Belgian medtech ecosystem. The fund provides not only financial support but also strategic guidance and access to a network of professionals in the life sciences and investment sectors.
What is the geographic scope of White Fund's investments?
White Fund primarily invests in Belgium but is open to opportunities in neighboring European countries. This geographic focus allows the fund to support local innovations while also exploring broader market potentials.
What is the typical fund size and check size for investments?
White Fund has a financial capacity of €38 million, with typical investment tickets ranging from €2 million to €5 million per project. The fund may consider larger investments through co-investment strategies.
What is White Fund's post-investment involvement with portfolio companies?
White Fund actively engages with its portfolio companies by providing strategic guidance and access to its network. The firm aims to support the commercialization of its investments and enhance their market impact.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.